Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15136498 | Publishing Date : 29-Jan-2020 | No. of pages : 90
Detailed TOC of Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Janus Kinase (JAK) Inhibitors Revenue
1.4 Market Analysis by Type
1.4.1 Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ruxolitinib
1.4.3 Tofacitinib
1.4.4 Oclacitinib
1.4.5 Baricitinib
1.4.6 Peficitinib
1.5 Market by Application
1.5.1 Global Janus Kinase (JAK) Inhibitors Market Share by Application: 2020 VS 2026
1.5.2 Autoimmune Disorders
1.5.3 Oncology
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Janus Kinase (JAK) Inhibitors Market Perspective (2015-2026)
2.2 Janus Kinase (JAK) Inhibitors Growth Trends by Regions
2.2.1 Janus Kinase (JAK) Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Janus Kinase (JAK) Inhibitors Historic Market Share by Regions (2015-2020)
2.2.3 Janus Kinase (JAK) Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Janus Kinase (JAK) Inhibitors Market Growth Strategy
2.3.6 Primary Interviews with Key Janus Kinase (JAK) Inhibitors Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Janus Kinase (JAK) Inhibitors Players by Market Size
3.1.1 Global Top Janus Kinase (JAK) Inhibitors Players by Revenue (2015-2020)
3.1.2 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Players (2015-2020)
3.1.3 Global Janus Kinase (JAK) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio
3.2.1 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Janus Kinase (JAK) Inhibitors Revenue in 2019
3.3 Janus Kinase (JAK) Inhibitors Key Players Head office and Area Served
3.4 Key Players Janus Kinase (JAK) Inhibitors Product Solution and Service
3.5 Date of Enter into Janus Kinase (JAK) Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Janus Kinase (JAK) Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Type (2021-2026)
5 Janus Kinase (JAK) Inhibitors Breakdown Data by Application (2015-2026)
5.1 Global Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020)
5.2 Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Janus Kinase (JAK) Inhibitors Market Size (2015-2020)
6.2 Janus Kinase (JAK) Inhibitors Key Players in North America (2019-2020)
6.3 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020)
6.4 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020)
7 Europe
7.1 Europe Janus Kinase (JAK) Inhibitors Market Size (2015-2020)
7.2 Janus Kinase (JAK) Inhibitors Key Players in Europe (2019-2020)
7.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020)
7.4 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020)
8 China
8.1 China Janus Kinase (JAK) Inhibitors Market Size (2015-2020)
8.2 Janus Kinase (JAK) Inhibitors Key Players in China (2019-2020)
8.3 China Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020)
8.4 China Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020)
9 Japan
9.1 Japan Janus Kinase (JAK) Inhibitors Market Size (2015-2020)
9.2 Janus Kinase (JAK) Inhibitors Key Players in Japan (2019-2020)
9.3 Japan Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020)
9.4 Japan Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Janus Kinase (JAK) Inhibitors Market Size (2015-2020)
10.2 Janus Kinase (JAK) Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020)
11 India
11.1 India Janus Kinase (JAK) Inhibitors Market Size (2015-2020)
11.2 Janus Kinase (JAK) Inhibitors Key Players in India (2019-2020)
11.3 India Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020)
11.4 India Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Janus Kinase (JAK) Inhibitors Market Size (2015-2020)
12.2 Janus Kinase (JAK) Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Astellas Pharma, Inc.
13.1.1 Astellas Pharma, Inc. Company Details
13.1.2 Astellas Pharma, Inc. Business Overview and Its Total Revenue
13.1.3 Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Introduction
13.1.4 Astellas Pharma, Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020))
13.1.5 Astellas Pharma, Inc. Recent Development
13.2 Eli Lilly and Co.
13.2.1 Eli Lilly and Co. Company Details
13.2.2 Eli Lilly and Co. Business Overview and Its Total Revenue
13.2.3 Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Introduction
13.2.4 Eli Lilly and Co. Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020)
13.2.5 Eli Lilly and Co. Recent Development
13.3 Incyte Corp.
13.3.1 Incyte Corp. Company Details
13.3.2 Incyte Corp. Business Overview and Its Total Revenue
13.3.3 Incyte Corp. Janus Kinase (JAK) Inhibitors Introduction
13.3.4 Incyte Corp. Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020)
13.3.5 Incyte Corp. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG Janus Kinase (JAK) Inhibitors Introduction
13.4.4 Novartis AG Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Details
13.5.2 Pfizer Inc. Business Overview and Its Total Revenue
13.5.3 Pfizer Inc. Janus Kinase (JAK) Inhibitors Introduction
13.5.4 Pfizer Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020)
13.5.5 Pfizer Inc. Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Janus Kinase (JAK) Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by Janus Kinase (JAK) Inhibitors Revenue
Table 3. Ranking of Global Top Janus Kinase (JAK) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ruxolitinib
Table 6. Key Players of Tofacitinib
Table 7. Key Players of Oclacitinib
Table 8. Key Players of Baricitinib
Table 9. Key Players of Peficitinib
Table 10. Global Janus Kinase (JAK) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Janus Kinase (JAK) Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Janus Kinase (JAK) Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2015-2020)
Table 14. Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Janus Kinase (JAK) Inhibitors Market Growth Strategy
Table 20. Main Points Interviewed from Key Janus Kinase (JAK) Inhibitors Players
Table 21. Global Janus Kinase (JAK) Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 22. Global Janus Kinase (JAK) Inhibitors Market Share by Players (2015-2020)
Table 23. Global Top Janus Kinase (JAK) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Janus Kinase (JAK) Inhibitors as of 2019)
Table 24. Global Janus Kinase (JAK) Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Janus Kinase (JAK) Inhibitors Product Solution and Service
Table 27. Date of Enter into Janus Kinase (JAK) Inhibitors Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 30. Global Janus Kinase (JAK) Inhibitors Market Size Share by Type (2015-2020)
Table 31. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2021-2026)
Table 32. Global Janus Kinase (JAK) Inhibitors Market Size Share by Application (2015-2020)
Table 33. Global Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 34. Global Janus Kinase (JAK) Inhibitors Market Size Share by Application (2021-2026)
Table 35. North America Key Players Janus Kinase (JAK) Inhibitors Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Janus Kinase (JAK) Inhibitors Market Share (2019-2020)
Table 37. North America Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 38. North America Janus Kinase (JAK) Inhibitors Market Share by Type (2015-2020)
Table 39. North America Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 40. North America Janus Kinase (JAK) Inhibitors Market Share by Application (2015-2020)
Table 41. Europe Key Players Janus Kinase (JAK) Inhibitors Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Janus Kinase (JAK) Inhibitors Market Share (2019-2020)
Table 43. Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Janus Kinase (JAK) Inhibitors Market Share by Type (2015-2020)
Table 45. Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Janus Kinase (JAK) Inhibitors Market Share by Application (2015-2020)
Table 47. China Key Players Janus Kinase (JAK) Inhibitors Revenue (2019-2020) (Million US$)
Table 48. China Key Players Janus Kinase (JAK) Inhibitors Market Share (2019-2020)
Table 49. China Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 50. China Janus Kinase (JAK) Inhibitors Market Share by Type (2015-2020)
Table 51. China Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 52. China Janus Kinase (JAK) Inhibitors Market Share by Application (2015-2020)
Table 53. Japan Key Players Janus Kinase (JAK) Inhibitors Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Janus Kinase (JAK) Inhibitors Market Share (2019-2020)
Table 55. Japan Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Janus Kinase (JAK) Inhibitors Market Share by Type (2015-2020)
Table 57. Japan Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Janus Kinase (JAK) Inhibitors Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Janus Kinase (JAK) Inhibitors Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Janus Kinase (JAK) Inhibitors Market Share (2019-2020)
Table 61. Southeast Asia Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Janus Kinase (JAK) Inhibitors Market Share by Type (2015-2020)
Table 63. Southeast Asia Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Janus Kinase (JAK) Inhibitors Market Share by Application (2015-2020)
Table 65. India Key Players Janus Kinase (JAK) Inhibitors Revenue (2019-2020) (Million US$)
Table 66. India Key Players Janus Kinase (JAK) Inhibitors Market Share (2019-2020)
Table 67. India Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 68. India Janus Kinase (JAK) Inhibitors Market Share by Type (2015-2020)
Table 69. India Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 70. India Janus Kinase (JAK) Inhibitors Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Janus Kinase (JAK) Inhibitors Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Janus Kinase (JAK) Inhibitors Market Share (2019-2020)
Table 73. Central & South America Janus Kinase (JAK) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Janus Kinase (JAK) Inhibitors Market Share by Type (2015-2020)
Table 75. Central & South America Janus Kinase (JAK) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Janus Kinase (JAK) Inhibitors Market Share by Application (2015-2020)
Table 77. Astellas Pharma, Inc. Company Details
Table 78. Astellas Pharma, Inc. Business Overview
Table 79. Astellas Pharma, Inc. Product
Table 80. Astellas Pharma, Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020) (Million US$)
Table 81. Astellas Pharma, Inc. Recent Development
Table 82. Eli Lilly and Co. Company Details
Table 83. Eli Lilly and Co. Business Overview
Table 84. Eli Lilly and Co. Product
Table 85. Eli Lilly and Co. Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020) (Million US$)
Table 86. Eli Lilly and Co. Recent Development
Table 87. Incyte Corp. Company Details
Table 88. Incyte Corp. Business Overview
Table 89. Incyte Corp. Product
Table 90. Incyte Corp. Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020) (Million US$)
Table 91. Incyte Corp. Recent Development
Table 92. Novartis AG Company Details
Table 93. Novartis AG Business Overview
Table 94. Novartis AG Product
Table 95. Novartis AG Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020) (Million US$)
Table 96. Novartis AG Recent Development
Table 97. Pfizer Inc. Company Details
Table 98. Pfizer Inc. Business Overview
Table 99. Pfizer Inc. Product
Table 100. Pfizer Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2015-2020) (Million US$)
Table 101. Pfizer Inc. Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Janus Kinase (JAK) Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. Ruxolitinib Features
Figure 3. Tofacitinib Features
Figure 4. Oclacitinib Features
Figure 5. Baricitinib Features
Figure 6. Peficitinib Features
Figure 7. Global Janus Kinase (JAK) Inhibitors Market Share by Application: 2020 VS 2026
Figure 8. Autoimmune Disorders Case Studies
Figure 9. Oncology Case Studies
Figure 10. Janus Kinase (JAK) Inhibitors Report Years Considered
Figure 11. Global Janus Kinase (JAK) Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Janus Kinase (JAK) Inhibitors Market Share by Regions: 2020 VS 2026
Figure 13. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Janus Kinase (JAK) Inhibitors Market Share by Players in 2019
Figure 16. Global Top Janus Kinase (JAK) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Janus Kinase (JAK) Inhibitors as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Janus Kinase (JAK) Inhibitors Revenue in 2019
Figure 18. North America Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Astellas Pharma, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Astellas Pharma, Inc. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2015-2020)
Figure 27. Eli Lilly and Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eli Lilly and Co. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2015-2020)
Figure 29. Incyte Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Incyte Corp. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2015-2020)
Figure 31. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis AG Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2015-2020)
Figure 33. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Inc. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed
Keyplayers in Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2020-2026
Astellas Pharma, Inc.Eli Lilly and Co.
Incyte Corp.
Novartis AG
Pfizer Inc.